Aptahem AB Company Description

Aptahem AB (publ), a clinical stage biotechnology company, develops aptamer-based pharmaceuticals for the treatment of acute life-threatening conditions.

Its principal pharmaceutical candidate is Apta-1, which is in preclinical stage to prevent mortality rate caused by organ and tissue damage in sepsis patients.

The company has collaborations with various academic groups, including Consortium with Orebro University, Seattle Children’s Research Institute, and University Health Network.

Aptahem AB (publ) was incorporated in 2014 and is based in Malmö, Sweden.

Aptahem AB (publ)

Country	Sweden
Founded	2014
Industry	Biological Products, Except Diagnostic Substances
Employees	4
CEO	Mikael Lindstam

Contact Details

Address: Norra Vallgatan 58, 4TR Malmö, 211 22 Sweden
Phone	46 7 66 02 01 99
Website	aptahem.com

Stock Details

Ticker Symbol	APTA
Exchange	Nordic Growth Market
Fiscal Year	January - December
Reporting Currency	SEK
SIC Code	2836

Key Executives

Name	Position
Mikael Lindstam	Co-Founder and Chief Executive Officer
Dr. Bert Junno	Co-Founder and Chairman
Dr. Kjell G. Stenberg	Chief Marketing Officer and Pres
Luiza Jedlina	Co-Founder and CSO
Ola Skanung	Chief Financial Officer
Maria Ekblad	Chief Operating Officer
Ulf Bjorklund M.Sc.	Senior Executive Advisor
Ingela Hallberg	Chief Medical Officer